Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Domperidone for nocturnal hypertension in sleep apnea-hypopnea syndrome (pilot)
2015-000645-23Phase 2Terminated
- Sponsor
- CiberMed
- Start
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of domperidone in nocturnal hypertension (NH) and sleep apnea, sponsored by CiberMed. Primary endpoints: Safety and tolerability of domperidone and Change in nocturnal blood pressure. Started Mar 2015; status: terminated.
02
Drugs
domperidone
03
Conditions
nocturnal hypertension (NH)sleep apnea
Beyond the preview
Go deeper on 2015-000645-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-000645-23.